drugset / Trial / NCT00007969

Photodynamic Therapy in Treating Patients With Stage III or Stage IV Melanoma

NCT00007969

Phase 1/2 Completed QLT Inc.
Treatment

Summary

RATIONALE: Photodynamic therapy uses light and drugs that make cancer cells more sensitive to light to kill tumor cells. Photodynamic therapy may be effective in treating melanoma. PURPOSE: Phase I/II trial to study the effectiveness of photodynamic therapy in treating patients who have stage III or stage IV melanoma.

Timeline

Start
2000-10
Primary completion
Completion

Drugs

EvaluationDrugModalityDoseRoute
Subject Detox-B Unknown
Subject Verteporfin Other / unclassified

Indications